Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› Statins and Cytochrome P450 interactions
› Reminder: Paroxetine prescribing advice
› Cisapride: Licences cancelledTolcapone (Tasmar): Return to market
› Review of the evidence regarding long-term safety of HRT
› Combined oral contraceptives: Venous thromboembolism
› Reminder: Thiazolidinediones (glitazones) contraindications
› Risk:benefit of co-proxamol
› SSI BCG vaccine and local reactions
› Changes in the names of certain medicines
› Reminder: Flucloxacillin and serious hepatic disorders
› Interaction between warfarin and cranberry juice: new advice
› Black cohosh (cimicifuga racemosa) and hepatotoxicity
› Reminder: Safety of Traditional Chinese Medicines and herbal remedies
› Dose adjustment and monitoring of Low Molecular Weight Heparins
› The Yellow Card Scheme
Current Problems in Pharmacovigilance October 2004 
